Germline JAK2 V617F mutation as a susceptibility gene causing myeloproliferative neoplasm in first-degree relatives

Leuk Lymphoma. 2020 Dec;61(13):3251-3254. doi: 10.1080/10428194.2020.1802448. Epub 2020 Aug 7.

Authors

Hee Sue Park^{1

2}, Bo Ra Son², Kyeong Seob Shin², Hee Kyung Kim^{3

4}, Yaewon Yang^{3

4}, Yusook Jeong³, Hye Sook Han⁴, Ki Hyeong Lee⁴, Jihyun Kwon⁴

Affiliations

¹ Laboratory Medicine, Chungbuk National University Hospital, Cheongju, Republic of Korea.
² Laboratory Medicine, Chungbuk National University College of Medicine, Cheongju, Republic of Korea.
³ Internal Medicine, Chungbuk National University Hospital, Cheongju, Republic of Korea.
⁴ Internal Medicine, Chungbuk National University College of Medicine, Cheongju, Republic of Korea.

PMID: 32762473
DOI: 10.1080/10428194.2020.1802448

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Bone Marrow Neoplasms*
Germ Cells
Humans
Janus Kinase 2 / genetics
Mutation
Myeloproliferative Disorders* / diagnosis
Myeloproliferative Disorders* / genetics

Substances

JAK2 protein, human
Janus Kinase 2